Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2026 (137)
  • 2025 (224)
  • 2024 (286)
  • 2023 (310)
  • 2022 (318)
  • 2021 (113)
  • 2020 (108)
  • 2019 (184)
  • 2018 (84)
  • 2017 (207)
  • 2016 (267)
  • 2015 (181)
  • 2014 (145)
  • 2013 (173)
  • 2012 (30)
  • 2011 (131)

Subject

  • Drug Trafficking (1127)
  • OCDETF/Task Force (398)
  • Guns/Weapons (310)
  • Fake Pills (127)
  • Money Laundering (48)
  • Prescription Drugs (48)
  • Diversion Division (47)
  • Gangs (44)
  • Take Back Day (31)
  • HIDTA (30)
  • Outreach/Drug Prevention (26)
  • Arrests/Convictions - Major (24)
  • Synthetic drugs (18)
  • Public and Media Affairs - also see Congressional Affairs (17)
  • Major Law Enforcement Operation (15)
  • Pharmaceuticals/Pharmacists/Physicians (15)
  • Congressional Affairs (12)
  • Fentanyl Awareness (12)
  • Press Conferences (12)
  • Counterfeit Pills (11)
  • One Pill Can Kill (11)
  • Red Ribbon (11)
  • Task Forces/Task Force Officers (11)
  • Fentanyl Free America (9)
  • Guilty Plea (9)
  • Prevention/Education - DEA websites GSAD, JTT etc (9)
  • Overdose (8)
  • Extraditions (5)
  • International/Foreign Operations (5)
  • Seizures (Drugs/Property) (5)
  • Intergovernmental Affairs (4)
  • Narcoterrorism (4)
  • Critical Incident (3)
  • Campaigns (2)
  • Cartel (2)
  • Scam Calls (2)
  • Terrorism (2)
  • Dark Web- Internet Trafficking (1)
  • Intelligence Division - Intelligence Products (1)
  • Museum and Visitors Center (1)
  • Other (1)

Drug Name

  • Fentanyl (854)
  • Cocaine (695)
  • Methamphetamine (299)
  • Heroin (285)
  • Marijuana (Cannabis) (70)
  • Oxycodone (70)
  • Ecstasy/MDMA (14)
  • Opioids (10)
  • Xylazine (10)
  • Synthetic Opioids (7)
  • Ketamine (6)
  • Hydromorphone (5)
  • Amphetamines (4)
  • Benzodiazepines (4)
  • LSD (4)
  • Steroids (3)
  • GHB (2)
  • Marijuana Concentrates (2)
  • Methadone (2)
  • Morphine (1)
  • Psilocybin (1)
  • Synthetic Bath Salts or Designer Cathinones (1)

Field Division

  • Atlanta (802)
  • Caribe (96)
  • Caribe (1)
  • Chicago (651)
  • Dallas (330)
  • Detroit (368)
  • El Paso (360)
  • Houston (929)
  • Los Angeles (316)
  • Louisville (96)
  • Miami (895)
  • New England (2470)
  • New Jersey (499)
  • New Orleans (515)
  • New York (1550)
  • Omaha (158)
  • Philadelphia (140)
  • Phoenix (278)
  • Rocky Mountain (169)
  • San Diego (251)
  • San Francisco (864)
  • Seattle (845)
  • Sede (433)
  • St. Louis (821)
  • Washington, DC (621)
Clear All Results
2898 Results - Showing 1461 to 1470
PRESS RELEASE

Alleged narcotrafficker and high ranking cartel member extradited from Uruguay to the United States

WASHINGTON – A Mexican national will have his initial appearance in federal court in the District of Columbia later today on charges related to his alleged involvement in a criminal conspiracy to distribute cocaine and methamphetamine. Assistant Attorney General Brian A. Benczkowski of the Justice Department’s Criminal Division and Acting...
PRESS RELEASE

Omnicare Inc. agrees to pay more than $15 million to resolve allegations it improperly dispensed narcotics at long-term care facilities

WASHINGTON – Omnicare Inc., a subsidiary of CVS Health and a leading provider of pharmacy services to long-term care facilities, has agreed to pay the United States a $15.3 million civil penalty to resolve allegations that it violated federal law by allowing opioids and other controlled substances to be dispensed...
PRESS RELEASE

Former chief of Honduran National Police charged with drug trafficking and weapons offenses

NEW YORK – DEA Special Operations Division Special Agent in Charge Wendy Woolcock and United States Attorney for the Southern District of New York Geoffrey S. Berman announced today that Juan Carlos Bonilla Valladares, aka “El Tigre,” was charged in Manhattan federal court with conspiring to import cocaine into the...
PRESS RELEASE

Six arrested after DEA Task Force investigation into fentanyl trafficking ring

HARTFORD, Conn. – DEA New England Division Special Agent in Charge Brian D. Boyle and John H. Durham, United States Attorney for the District of Connecticut announced that the following six men were arrested yesterday on federal narcotics distribution and money laundering charges related to the large-scale distribution of fentanyl...
PRESS RELEASE

Worcester man sentenced to 134 months for heroin and cocaine conspiracy

BOSTON – DEA New England Division Special Agent in Charge Brian D. Boyle and United States Attorney Andrew E. Lelling announced that Vito Nuzzolilo, 46, was sentenced during a videoconference hearing before U.S. District Court Judge Timothy S. Hillman to 134 months in prison and eight years of supervised release...
PRESS RELEASE

Rochester woman sentenced to 60 months for drug trafficking and firearm offenses

CONCORD, NH – DEA New England Division Special Agent in Charge Brian D. Boyle and United States Attorney Scott W. Murray announced that Haley Hansler, 33, of Rochester, was sentenced to 60 months in federal prison for participating in a drug trafficking conspiracy and possessing a firearm in furtherance of...
PRESS RELEASE

DEA launches Secure Your Meds campaign, calls on Americans to keep medications safe

WASHINGTON – With families encouraged to stay at home due to the nationwide health crisis, the Drug Enforcement Administration is asking Americans to keep prescription medications safe and secure until they can properly dispose of them. The Secure Your Meds awareness campaign addresses a vital public safety and health issue...
PRESS RELEASE

DEA releases 2020 Drugs of Abuse Resource Guide

WASHINGTON – The U.S. Drug Enforcement Administration has released the 2020 edition of Drugs of Abuse, A DEA Resource Guide , which is designed to be a reliable resource on the most commonly abused and misused drugs in the United States. Released on a periodic basis, Drugs of Abuse provides...
PRESS RELEASE

DEA takes additional steps to allow increased production of controlled substances used in COVID-19 care

WASHINGTON – The Drug Enforcement Administration announced today that it is increasing Aggregate Production Quotas available to pharmaceutical manufacturers for the production of controlled substance medications that are in high demand due to the coronavirus (COVID-19) pandemic. DEA will also approve increases in imports of medications necessary for patients on...
PRESS RELEASE

National Prescription Drug Take Back Day Postponed

WASHINGTON – The upcoming National Prescription Drug Take Back Day scheduled for Saturday, April 25, 2020 is postponed due to the ongoing coronavirus (COVID-19) pandemic. DEA will reschedule Take Back Day for a date shortly after the health crisis recedes and national emergency guidelines are lifted. The health and safety...

Paginación

  • Primera página «
  • Anterior
  • Página 143
  • Página 144
  • Página 145
  • Página 146
  • Current page 147
  • Página 148
  • Página 149
  • Página 150
  • Página 151
  • Siguiente
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster